Gabapentin Tablet
Product Images NDC 68001-411

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68001-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapenting Tablets 600mg (600mg Label 100s Goa)

Label for Gabapentin Tablets, USP 600 mg oral tablets by BluePoint Laboratories. The label indicates prescription use, packaging of 100 tablets, and includes the NDC 68001-411-00. Storage instructions specify 25°C with allowable excursions. Medication guide availability and dispensing instructions are also noted.*

FDA Label Image

Gabapetin Tablets 800 mg (800mg Label 100s Goa)

Gabapentin tablets, USP, 800 mg oral tablets packaging label by BluePoint Laboratories. The label includes dosage strength, storage instructions, a barcode, and directs pharmacists to dispense the medication guide separately. The package contains 100 tablets and is marked Rx only.*

FDA Label Image

Equation (Equation)

This image shows a formula for calculating creatinine clearance (CLCr), used to estimate kidney function based on age, weight, serum creatinine, and sex. It includes an adjustment factor of 0.85 for female patients.*

FDA Label Image

Fig1 (Fig1)

A line graph showing the mean pain score over 8 weeks for two groups: placebo and Gabapentin 3600 mg/day. The graph marks a 4-week dose titration period followed by a 4-week fixed dose period, with the Gabapentin group displaying a decreasing mean pain score over time compared to the placebo group.*

FDA Label Image

Fig2 (Fig2)

Line graph showing mean pain scores over 7 weeks comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The x-axis represents weeks, with a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, with Gabapentin groups showing lower pain scores than placebo over time.*

FDA Label Image

Fig3 (Fig3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) treatments in two studies. Study 1 shows 12% response for placebo and 29% for Gabapentin 3600 mg. Study 2 shows 14% for placebo and 32% and 34% for Gabapentin 1800 mg and 2400 mg respectively, with significance levels p < 0.01 and p < 0.001 indicated.*

FDA Label Image

Fig4 (Fig4)

A scatter plot showing the percentage difference versus daily dose (mg) for Gabapentin at doses 600, 900, 1200, and 1800 mg. The graph compares three studies labeled a, b, and c, each represented by different colored squares. Values vary across studies and doses, illustrating differences in response or measurement at each dose level.*

FDA Label Image

Image 01

Gabapentin Tablets USP 600 mg oral tablets label showing a 100 count package. Manufactured by Glenmark Pharmaceuticals Ltd., labeled for BluePoint Laboratories. The label includes storage instructions, a barcode, and instructs pharmacists to dispense the Medication Guide separately.*

FDA Label Image

Image 02

Gabapentin Tablets USP 800 mg oral tablets, packaged by BluePoint Laboratories, shown in a label that includes the NDC 68001-412-00 and directions for pharmacist dispensing. The label states that the bottle contains 100 tablets and provides storage instructions, dosage information, and a medication guide URL. The label also includes manufacturer details from Global Pharmaceuticals Ltd., India.*

FDA Label Image

Molecula Formula Gabapentin (Structure)

Chemical structure diagram of gabapentin showing the cyclohexane ring attached to an amino acid backbone with an amino group and a carboxylic acid group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.